Literature DB >> 12421434

Increasing prevalence of diabetes mellitus in Oman.

J A Al-Lawati1, A M Al Riyami, A J Mohammed, P Jousilahti.   

Abstract

AIMS: To determine the prevalence of diabetes mellitus and impaired fasting glucose by age, gender, and by region and compare results with the 1991 survey; and estimate previously undiagnosed diabetes mellitus in the Omani population.
METHODS: Cross-sectional survey containing a probability random sample of 5838 Omani adults aged >or= 20 years. Diabetes and impaired fasting glucose (IFG) were assessed by fasting venous plasma glucose using 1999 World Health Organization's diagnostic criteria (normoglycaemia < 6.1 mmol/l, IFG >or= 6.1 but < 7 mmol/l,and diabetes >or= 7 mmol/l). The 1991 survey was reanalysed using the same diagnostic criteria, and results were compared.
RESULTS: In 2000, the age-adjusted prevalence of diabetes among Omanis aged 30-64 years reached 16.1% (95% confidence interval (CI) 14.7-17.4) compared with 12.2% (95% CI11.0-13.4) in 1991. IFG was found among 7.1% (95% CI6.2-8.1) of males and 5.1% (95% CI 4.4-6.0) of females. Generally, diabetes was more common in urban then rural regions. Only one-third of diabetic subjects knew that they had diabetes. Nearly half of the study population had a body mass index > 25 kg/m2.
CONCLUSIONS: The prevalence of diabetes is high in Oman and has increased over the past decade. The high rate of abnormal fasting glucose together with high rates of overweight and obesity in the population make it likely that diabetes will continue to be a major health problem in Oman. Primary prevention programmes are urgently needed to counteract major risk factors that promote the development of diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421434     DOI: 10.1046/j.1464-5491.2002.00818.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  76 in total

1.  Type 2 Diabetes and its Characteristics during Ramadan in Dhahira Region, Oman.

Authors:  Prakash Patel; Anoop Mirakhur; Karim Mahmoud Abo El-Magd; Abdel Nasser Abo El-Matty; Dalal Al-Ghafri
Journal:  Oman Med J       Date:  2007-10

2.  Type 2 Diabetes in Oman: Can we learn from the Lancet editorial.

Authors:  Asya Al-Riyami
Journal:  Oman Med J       Date:  2010-07

3.  Re: Acute Coronary Syndrome, Diabetes and Hypertension: Oman must pay more attention to chronic non-communicable diseases.

Authors:  Moeness Moustafa Alshishtawy
Journal:  Sultan Qaboos Univ Med J       Date:  2012-02-07

4.  Characteristics of Registered Diabetics in Dhank Province in the Sultanate of Oman.

Authors:  Faisal Rabia Al-Rubaee; Moza Humaid Al-Abri
Journal:  Oman Med J       Date:  2016-05

5.  Care of diabetic retinopathy patients in oman.

Authors:  Rajiv Khandekar; Ali Jaffer Mohammed; Jawad A Al-Lawati
Journal:  Sultan Qaboos Univ Med J       Date:  2008-03

6.  Obesity among Sudanese adults with diabetes: a population-based survey.

Authors:  Yasmeen A Ali; Ahmed O Almobarak; Heitham Awadalla; Wadie M Elmadhoun; Mohamed H Ahmed
Journal:  Ann Transl Med       Date:  2017-06

7.  HbA1c Levels among Primary Healthcare Patients with Type 2 Diabetes Mellitus in Oman.

Authors:  Jawad A Al-Lawati; Mohammed N Barakat; Masoud Al-Maskari; Medhat K Elsayed; Alya M Al-Lawati; Ali Jaffer Mohammed
Journal:  Oman Med J       Date:  2012-11

8.  Prevalence Pattern of Risk Factors for Coronary Artery Disease among Patients Presenting for Coronary Artery Bypass Grafting in Oman.

Authors:  Rajeeva Rivikath Pieris; Hilal Ali Al-Sabti; Qasim Saleh Abdullah Al-Abri; Syed Gauhar Alam Rizvi
Journal:  Oman Med J       Date:  2014-05

9.  Gender inequality in vision loss and eye diseases: evidence from the Sultanate of Oman.

Authors:  Rajiv Khandekar; A J Mohammed
Journal:  Indian J Ophthalmol       Date:  2009 Nov-Dec       Impact factor: 1.848

10.  Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran.

Authors:  Hadi Harati; Farzad Hadaegh; Navid Saadat; Fereidoun Azizi
Journal:  BMC Public Health       Date:  2009-06-16       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.